首页>Pediatric blood & cancer.>A PHASE II PREVENTION TRIAL OF DFMO IN PATIENTS WITH HIGH RISK NEUROBLASTOMA IN REMISSION PREVENTS RELAPSE AND INCREASES EVENT FREE AND OVERALL SURVIVAL
A PHASE II PREVENTION TRIAL OF DFMO IN PATIENTS WITH HIGH RISK NEUROBLASTOMA IN REMISSION PREVENTS RELAPSE AND INCREASES EVENT FREE AND OVERALL SURVIVAL